New York State Common Retirement Fund
ADMS

New York State Common Retirement Fund’s Adamas Pharmaceuticals ADMS Stock Holding History

New York State Common Retirement Fund’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-12,700
Closed -$37K – 3325
2020
Q1 		$37K Hold
12,700
– – ﹤0.01% 3044
2019
Q4 		$48K Hold
12,700
– – ﹤0.01% 3132
2019
Q3 		$65K Hold
12,700
– – ﹤0.01% 3128
2019
Q2 		$79K Hold
12,700
– – ﹤0.01% 3162
2019
Q1 		$90K Sell
12,700
-11,800
-48% -$106K ﹤0.01% 2980
2018
Q4 		$209K Hold
24,500
– – ﹤0.01% 2691
2018
Q3 		$490K Hold
24,500
– – ﹤0.01% 2416
2018
Q2 		$633K Buy
24,500
+6,400
+35% +$177K ﹤0.01% 2346
2018
Q1 		$433K Sell
18,100
-4,189
-19% -$132K ﹤0.01% 2417
2017
Q4 		$755K Buy
22,289
+4,189
+23% +$117K ﹤0.01% 2175
2017
Q3 		$383K Hold
18,100
– – ﹤0.01% 2493
2017
Q2 		$317K Sell
18,100
-1
-0% -$17 ﹤0.01% 2641
2017
Q1 		$317K Buy
18,101
+1
+0% +$17 ﹤0.01% 2598
2016
Q4 		$306K Hold
18,100
– – ﹤0.01% 2603
2016
Q3 		$297K Hold
18,100
– – ﹤0.01% 2588
2016
Q2 		$274K Buy
18,100
+8,600
+91% +$142K ﹤0.01% 2575
2016
Q1 		$137K Hold
9,500
– – ﹤0.01% 2836
2015
Q4 		$269K Hold
9,500
– – ﹤0.01% 2610
2015
Q3 		$159K Buy
9,500
+2,113
+29% +$48.1K ﹤0.01% 2882
2015
Q2 		$194K Buy
+7,387
New +$144K ﹤0.01% 2927

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

New York State Common Retirement Fund's ADMS Position: Q2 2020 in Review

New York State Common Retirement Fund sold out of Adamas Pharmaceuticals (ADMS) in Q2 2020, closing a stake of 12,700 shares — an estimated $37K sold.

New York State Common Retirement Fund first reported a position in ADMS in Q2 2015 and held it in 20 quarters. The position peaked at $755K in Q4 2017. 61 funds tracked by Wall St. Rank hold ADMS as of Q2 2020.

  • New York State Common Retirement Fund reported no remaining Adamas Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • New York State Common Retirement Fund sold 12,700 Adamas Pharmaceuticals shares in Q2 2020, an estimated $37K.
  • New York State Common Retirement Fund first reported a position in Adamas Pharmaceuticals in Q2 2015 and held it in 20 quarters.
  • New York State Common Retirement Fund's Adamas Pharmaceuticals position peaked at $755K in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2020.

Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.